• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Hong Kong·Healthcare·8372.HK
Share

Grand Brilliance Group Holdings Limited Stocks

HK$ 0.14Last Updated 17.08.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

HK$ 14.68M

HK$ 0.14
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Grand Brilliance Group Holdings Limited, an investment holding entity, primarily operates by distributing medical equipment and related items across Hong Kong. Its extensive product portfolio encompasses various medical supplies, including disposables, specialized instruments, and advanced medical machinery. The company also undertakes the development of innovative healthcare products. Beyond product distribution, it delivers comprehensive medical device solutions such as in-depth market trend assessments, strategic sourcing, post-sale support, technical training, equipment rental, and stringent quality assurance. Additionally, the firm manages maintenance services and holds several registered trademarks. Its diverse client base spans both public and private healthcare facilities, independent clinics, charitable groups, academic institutions, and direct consumers. Established in 1997, the company is headquartered in Tsuen Wan, Hong Kong, and operates as a subsidiary of B&A Success Limited.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair va

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

18.08.2026 15:23

Morning in New York: Focus on Rising Treasury Yields and Geopolitical Risks

18.08.2026 14:13

The "Panda" Loan: Why Yuan-Denominated Loans Are Attractive Not Only to Kazakhstan

18.08.2026 13:53

Druckenmiller sold Micron and Broadcom before the crash. What did he double down on?

18.08.2026 12:44

Yields on global government bonds have reached multi-year highs. What's going on?

18.08.2026 11:23

A malfunction in the rearview cameras forced Stellantis to recall nearly 1 million cars worldwide

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026